BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2155138)

  • 1. Surgical implications of population screening for mammary carcinoma.
    Wobbes T
    Eur J Surg Oncol; 1990 Feb; 16(1):15-7. PubMed ID: 2155138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast carcinoma-in-situ: an emerging problem in Singapore.
    Chua CL; Tan PK; Chiang G; Soo KC; Low CH
    Singapore Med J; 1992 Aug; 33(4):383-5. PubMed ID: 1329232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical treatment of non-palpable breast tumors].
    Lázár G; Ormándi K; Hajnal PR; Zöllei I; Szentpáli K; Paszt A; Kallai A; Kahán Z; Balogh A
    Orv Hetil; 2002 Jan; 143(2):77-81. PubMed ID: 11868452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late recurrence of ductal carcinoma in situ at the cutaneous end of surgical drainage following total mastectomy.
    Finkelstein SD; Sayegh R; Thompson WR
    Am Surg; 1993 Jul; 59(7):410-4. PubMed ID: 8391769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
    Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
    Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Minimal carcinoma of the breast: incidence on mass screening].
    Virno F
    Minerva Chir; 1989 Feb; 44(3):399-400. PubMed ID: 2541373
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast cancer risk factors: can we select women for prophylactic mastectomy?
    Schechter MT
    Can J Surg; 1985 May; 28(3):242-4, 247. PubMed ID: 2986806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraduct carcinoma of the breast (duct carcinoma in situ).
    Lange M; Kessel I; Kessler E; Lakier RH; Lange NR; Ross-Thompson S
    S Afr J Surg; 1994 Jun; 32(2):59-61. PubMed ID: 7502173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conservative treatment of ductal carcinoma in situ of the breast].
    Hepp R; Baeza MR
    Rev Med Chil; 1999 Nov; 127(11):1345-50. PubMed ID: 10835721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous mastectomy and immediate prosthetic implantation as an alternative to simple mastectomy.
    Inglis FG; Midgley RD
    Can J Surg; 1974 Jan; 17(1):63-7. PubMed ID: 4359827
    [No Abstract]   [Full Text] [Related]  

  • 11. Should the hunt for nonpalpable breast lesions be called off?
    Wright CJ
    Can J Surg; 1986 Sep; 29(5):299-300. PubMed ID: 3756645
    [No Abstract]   [Full Text] [Related]  

  • 12. [Conservative surgery for ductal carcinoma in situ of the breast].
    Tersigni R; Mencacci R; Alessandroni L; Baiano G; Mardarella C; Parisi A
    Minerva Chir; 2003 Aug; 58(4):563-9. PubMed ID: 14603170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The surgeon and mass screening for breast cancer].
    Wobbes T; Tinnemans JG
    Ned Tijdschr Geneeskd; 1986 Nov; 130(47):2116-7. PubMed ID: 3025751
    [No Abstract]   [Full Text] [Related]  

  • 14. In situ carcinomas of the breast. Types, growth pattern, diagnosis, and treatment.
    Andersen J; Blichert-Toft M; Dyreborg U
    Eur J Surg Oncol; 1987 Apr; 13(2):105-11. PubMed ID: 3030823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical strategy in carcinoma of the breast in relation to the TNM].
    Badellino F; Canavese G
    Minerva Chir; 1988 Sep; 43(18 Suppl):13-5. PubMed ID: 2852315
    [No Abstract]   [Full Text] [Related]  

  • 16. Mammographic wire localization in diagnosis and treatment of occult carcinoma of breast.
    Petrovich JA; Ross DS; Sullivan JW; Lake TP
    Surg Gynecol Obstet; 1989 Mar; 168(3):239-43. PubMed ID: 2537536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of ductal carcinoma in situ by the pathologist: current questions].
    Arnould L; Caron Y; Sigal-Zafrani B
    Ann Pathol; 2003 Dec; 23(6):534-46. PubMed ID: 15094591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The non-palpable, radiographically suspicious breast lesion: an analysis of 101 cases.
    Perre CI; Hoynck van Papendrecht AA; Sierink HD; Muller JW
    Neth J Surg; 1990 Jun; 42(3):69-71. PubMed ID: 2164172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for pathology--supplement to European guidelines for quality assurance in mammography screening. Report by the Pathology Working Group of the European Community].
    Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Böcker W; Bussolati G; Connolly CE; De Miguel C; Dervan P; Drijkoningen R; Elston CW; Faverly D; Gad A; Holland R; Jacquemier J; Lacerda M; Lindgren A; Martinez-Peñuela J; Peterse JL; Rank F; Tsakraklides V; de Wolf C; Zafrani B
    Pathologe; 1997 Jan; 18(1):71-88. PubMed ID: 9157408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.